Bone Microthrombus Promotes Bone Loss in Iron Accumulation Rats

Curr Med Sci. 2020 Oct;40(5):943-950. doi: 10.1007/s11596-020-2251-8. Epub 2020 Oct 29.

Abstract

In the present study, we investigated the changes of the coagulation state, bone microthrombus, microvascular bed and bone density levels in iron accumulation rats. Meanwhile,the effect of anticoagulation therapy on bone mineral density was further investigated. We established two groups: a control (Ctrl) group and an iron intervention (FAC) group. Changes in coagulation function, peripheral blood cell counts, bone microthrombus, bone vessels and bone mineral density were compared between the two groups. We designed the non-treatment group and treatment group to study the changes of bone mineral density by preventing microthrombus formation with the anticoagulant fondaparinux. We found that the fibrinogen and D-dimer contents were significantly higher, whereas the thrombin time (TT) and prothrombin time (PT) were significantly shorter in the FAC group. After ink staining, the microvascular bed in the FAC group was significantly reduced compared with that in the Ctrl group. HE and Martius Scarlet Blue (MSB) staining showed microthrombus in the bone marrow of the iron accumulation rats. Following anticoagulation therapy, the bone microcirculation vascular bed areas in the treatment group rats were significantly increased. Furthermore, the bone mineral density was increased in the treatment group compared with that in the non-treatment group. Through experiments, we found that the blood in iron accumulation rat was relatively hypercoagulable; moreover, there was microthrombus in the bone marrow, and the bone vascular bed was reduced. Additionally, anticoagulation was helpful for improving bone microcirculation, reducing microthrombus and decreasing bone loss.

Keywords: anticoagulant; bone microthrombus; coagulation state; iron accumulation; microvascular bed; osteoporosis.

MeSH terms

  • Animals
  • Blood Coagulation / genetics
  • Bone Density / genetics
  • Bone Resorption / complications
  • Bone Resorption / genetics
  • Bone Resorption / metabolism*
  • Bone Resorption / pathology
  • Disease Models, Animal
  • Fibrin Fibrinogen Degradation Products / genetics
  • Fibrinogen / genetics*
  • Fibrinogen / metabolism
  • Humans
  • Iron / metabolism*
  • Iron / pharmacology
  • Rats
  • Thrombosis / complications
  • Thrombosis / genetics
  • Thrombosis / metabolism*
  • Thrombosis / pathology

Substances

  • Fibrin Fibrinogen Degradation Products
  • fibrin fragment D
  • Fibrinogen
  • Iron